1. Home
  2. Labeler Index
  3. Astellas Pharma Inc.
  4. 12838-1330
  5. NDC Package Code: 12838-1330-9 Tacrolimus

NDC Package 12838-1330-9 Tacrolimus

Granule, For Suspension - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
12838-1330-9
Package Description:
3000 GRANULE, FOR SUSPENSION in 1 BOX
Product Code:
12838-1330
Non-Proprietary Name:
Tacrolimus
Substance Name:
Tacrolimus
Usage Information:
Tacrolimus is used with other medications to prevent rejection of a kidney transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.
11-Digit NDC Billing Format:
12838133009
Product Type:
Drug For Further Processing
Labeler Name:
Astellas Pharma Inc.
Dosage Form:
Granule, For Suspension - A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient.
Active Ingredient(s):
TACROLIMUS 1 mg/1
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
05-24-2018
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 12838-1330-9?

The NDC Packaged Code 12838-1330-9 is assigned to an UNFINISHED drug package of 3000 granule, for suspension in 1 box of Tacrolimus, drug for further processing labeled by Astellas Pharma Inc.. The product's dosage form is granule, for suspension and is administered via form.

Is NDC 12838-1330 included in the NDC Directory?

Yes, Tacrolimus is an UNFINISHED PRODUCT with code 12838-1330 that is active and included in the NDC Directory. The product was first marketed by Astellas Pharma Inc. on May 24, 2018 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 12838-1330-9?

The 11-digit format is 12838133009. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-112838-1330-95-4-212838-1330-09